カテゴリー： Transparency Market Research, 世界, 医療/バイオ

HIV/AIDS診断の世界市場（2022～2031）：製品別、検査種類別

◆英語タイトル：HIV/AIDS Diagnostics Market (Product: Kits and Reagents and Instruments; and Test Type: Nucleic Acid Tests, Rapid Tests, ELISA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが発行した調査報告書（TMR23AP096）◆商品コード：TMR23AP096
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年1月10日
◆ページ数：180
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の本調査レポートでは、HIV/AIDS診断の世界市場について総合的に分析し、今後の市場動向を予測しています。本書は、序論、仮定＆調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（キット＆試薬、機器）分析、検査種類別（核酸検査、迅速検査、ELISA、その他）分析、エンドユーザー別（病院、診断検査室、学術研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目が整理されています。また、本書内には、Hologic, Inc.、Abbott、Bio-Rad Laboratories, Inc.、F. Hoffmann-La Roche Ltd.、OraSure Technologies, Inc.、Siemens Healthcare GmbH、Chembio Diagnostics, Inc.、Danaher Corporation、Becton, Dickinson and Companyなどの企業情報が含まれています。
・序論
・仮定＆調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のHIV/AIDS診断市場規模：製品別
- キット＆試薬の市場規模
- 機器の市場規模
・世界のHIV/AIDS診断市場規模：検査種類別
- 核酸検査の市場規模
- 迅速検査の市場規模
- ELISAの市場規模
- その他検査種類の市場規模
・世界のHIV/AIDS診断市場規模：エンドユーザー別
- 病院における市場規模
- 診断検査室における市場規模
- 学術研究機関における市場規模
- その他エンドユーザーにおける市場規模
・世界のHIV/AIDS診断市場規模：地域別
- 北米のHIV/AIDS診断市場規模
- ヨーロッパのHIV/AIDS診断市場規模
- アジア太平洋のHIV/AIDS診断市場規模
- 中南米のアルミニウムスラグ市場規模
- 中東・アフリカのアルミニウムスラグ市場規模
・競争状況

HIV/AIDS Diagnostics Market – Scope of Report
TMR’s report on the global HIV/AIDS diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global HIV/AIDS diagnostics market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global HIV/AIDS diagnostics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the HIV/AIDS diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global HIV/AIDS diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global HIV/AIDS diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global HIV/AIDS diagnostics market.

The report delves into the competitive landscape of the global HIV/AIDS diagnostics market. Key players operating in the global HIV/AIDS diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global HIV/AIDS diagnostics market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market HIV/AIDS diagnostics.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global HIV/AIDS Diagnostics Market
4. Market Overview
    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution/Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global HIV/AIDS Diagnostics Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projection (US$ Mn)
        4.4.2. Market Volume/Unit Shipments Projection
    4.5. Porter’s Five Forces Analysis
5. Key Insights
    5.1. HIV Disease Epidemiology
    5.2. Technological Advancements
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product, 2017–2031
        6.3.1. Kits and Reagents
        6.3.2. Instruments
    6.4. Market Attractiveness Analysis, by Product
7. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Test Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Test Type, 2017–2031
        7.3.1. Nucleic Acid Tests
        7.3.2. Rapid Tests (POC)
        7.3.3. ELISA
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by Test Type
8. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Diagnostic Laboratories
        8.3.3. Academic and Research Institutes
        8.3.4. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017–2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America HIV/AIDS Diagnostics Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017–2031
        10.2.1. Kits and Reagents
        10.2.2. Instruments
    10.3. Market Value Forecast, by Test Type, 2017–2031
        10.3.1. Nucleic Acid Tests
        10.3.2. Rapid Tests (POC)
        10.3.3. ELISA
        10.3.4. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Diagnostic Laboratories
        10.4.3. Academic and Research Institutes
        10.4.4. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Test Type
        10.6.3. By End-user
        10.6.4. By Country
11. Europe HIV/AIDS Diagnostics Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017–2031
        11.2.1. Kits and Reagents
        11.2.2. Instruments
    11.3. Market Value Forecast, by Test Type, 2017–2031
        11.3.1. Nucleic Acid Tests
        11.3.2. Rapid Tests (POC)
        11.3.3. ELISA
        11.3.4. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Diagnostic Laboratories
        11.4.3. Academic and Research Institutes
        11.4.4. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Test Type
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific HIV/AIDS Diagnostics Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017–2031
        12.2.1. Kits and Reagents
        12.2.2. Instruments
    12.3. Market Value Forecast, by Test Type, 2017–2031
        12.3.1. Nucleic Acid Tests
        12.3.2. Rapid Tests (POC)
        12.3.3. ELISA
        12.3.4. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Diagnostic Laboratories
        12.4.3. Academic and Research Institutes
        12.4.4. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Test Type
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America HIV/AIDS Diagnostics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017–2031
        13.2.1. Kits and Reagents
        13.2.2. Instruments
    13.3. Market Value Forecast, by Test Type, 2017–2031
        13.3.1. Nucleic Acid Tests
        13.3.2. Rapid Tests (POC)
        13.3.3. ELISA
        13.3.4. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Diagnostic Laboratories
        13.4.3. Academic and Research Institutes
        13.4.4. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Test Type
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa HIV/AIDS Diagnostics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product, 2017–2031
        14.2.1. Kits and Reagents
        14.2.2. Instruments
    14.3. Market Value Forecast, by Test Type, 2017–2031
        14.3.1. Nucleic Acid Tests
        14.3.2. Rapid Tests (POC)
        14.3.3. ELISA
        14.3.4. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Diagnostic Laboratories
        14.4.3. Academic and Research Institutes
        14.4.4. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Test Type
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company (2021)
    15.3. Company Profiles
        15.3.1. Hologic, Inc
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. Abbott
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. Bio-Rad Laboratories, Inc.
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. F. Hoffmann-La Roche Ltd.
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. OraSure Technologies, Inc.
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Product Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
        15.3.6. Siemens Healthcare GmbH
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
        15.3.7. Chembio Diagnostics, Inc.
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
        15.3.8. Danaher Corporation
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
        15.3.9. Becton, Dickinson and Company
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Product Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis

List of Tables

Table 01: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 07: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 08: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 12: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 16: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 20: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 24: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ HIV/AIDS診断の世界市場（2022～2031）：製品別、検査種類別(HIV/AIDS Diagnostics Market (Product: Kits and Reagents and Instruments; and Test Type: Nucleic Acid Tests, Rapid Tests, ELISA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のがん診断市場2022年-2031年：検査種類別（腫瘍バイオマーカー検査、画像診断、内視鏡検査、生体検査）、エンドユーザー別
  • 遺伝子検査サービスの世界市場2023～2031：検査種類別
  • 世界のインフルエンザ診断市場2023-2031：検査別（RT-PCR検査、インフルエンザ迅速診断検査、ウイルス培養、免疫蛍光アッセイ、血清学的検査、その他）
  • 強皮症診断・治療の世界市場2023-2031：産業分析、規模、シェア、成長、動向、予測

    • ◆H&Iグローバルリサーチのお客様（例）◆